Article
Impact of beta‐2 microglobulin expression on the survival of glioma patients via modulating the tumor immune microenvironment
7 May 2021
Abstract excerpt
AIMS: High immune cell infiltration in gliomas establishes an immunosuppressive tumor microenvironment, which in turn promotes resistance to immunotherapy. Hence, it is important to identify novel targets associated with high immune cell infiltration in gliomas. Our previous study showed that serum levels of beta-2 microglobulin (B2M) in lower-grade glioma patients were lower than those in glioblastoma patients....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
